SCHEMBL6290685

SCHEMBL6290685

Fc1cccc(Oc2cccc(Oc3ccccc3Oc3ccccc3Oc3ccccc3Oc3cccc(Oc4cccc(F)c4)c3)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.53
SLC6A2 P23975 6/20 0.53
SLC6A3 Q01959 5/20 0.53
HTR1A P08908 3/20 0.53
HTR2A P28223 1/20 0.42
SLC1A5 Q15758 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
GAA P10253 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MITF O75030 1/20 0.41
GFER P55789 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NLRP1 Q9C000 1/20 0.41
NOD2 Q9HC29 1/20 0.41
USP2 O75604 1/20 0.40
CYP1A2 P05177 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6290704 1.00 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6289809 0.98 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290677 0.98 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290458 0.98 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290672 0.96 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6293111 0.96 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290492 0.96 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290645 0.96 SLC6A4 (0.55) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6290671 0.94 SLC6A4 (0.51) SLC6A4SLC6A2SLC6A3HTR1AHTR2A
SCHEMBL6293934 0.94 SLC6A4 (0.51) SLC6A4SLC6A2SLC6A3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SLC6A4 1103/4885SLC6A2 2617/4885SLC6A3 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.